ADPT
AdaptiveยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ADPT Profile
Adaptive Biotechnologies Corporation
A commercial stage biotech company that translates the genetics of the adaptive immune system into clinical products to diagnose and treat disease
Life Science Tools and Services
09/08/2009
06/27/2019
NASDAQ Stock Exchange
619
12-31
Common stock
1165 Eastlake Avenue East, Seattle, Washington 98109
--
Adaptive Biotechnologies Corporation was incorporated in Washington State on September 8, 2009. The company is advancing the field of immune-driven medicine by leveraging the inherent biology of the adaptive immune system to transform the diagnosis and treatment of diseases. The company believes that the adaptive immune system is nature's most sophisticated diagnosis and treatment for most diseases, but the inability to decode it prevents the medical community from taking full advantage of its capabilities. The company's immunomedicine platform applies proprietary technology to read multiple genetic codes of a patient's immune system and understand exactly how to detect and treat that patient's disease. The company's immunomedicine platform applies proprietary technology to read multiple genetic codes of a patient's immune system and understand exactly how to detect and treat that patient's disease. The company captures these insights in the Dynamic Clinical Immunomics Database, which is based on computational biology and machine learning for the development and commercialization of clinical products and services that companies are tailoring to each patient.
